NCT04396587View on ClinicalTrials.gov

Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

January 1, 2023

Study Completion Date

June 1, 2023

Conditions
Opioid Use
Interventions
DRUG

Sufentanil

Sufentanil(0.1μg/kg) was administered before anesthesia induction.

DRUG

Hydromorphone

Hydromorphone(20μg/kg)was administered before anesthesia induction.

DRUG

Oxycodone

Oxycodone(60μg/kg) was administered before anesthesia induction.

DRUG

normal Saline

normal saline 10ml

Trial Locations (1)

100044

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT04396587 - Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone | Biotech Hunter | Biotech Hunter